Clever Leaves Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2023 to a ratio of 8.39, this represents a new company high. This is a clear indication for improving liquidity at Clever Leaves Holdings Inc 's clients. Average receivable collection period, for the Clever Leaves Holdings Inc in Dec 31 2023 quarter, has decreased to 44 days, compared to 52 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 165 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1702, from overall ranking in the third quarter 2023 at 1907.

What is Receivable Turnover Ratio?
What is Clever Leaves Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CLVR Receivables Turnover Ratio	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Receivable Change	-59.72 %	-32.61 %	-23.62 %	-50.82 %	-51.23 %
Y / Y Revenue Change	6.42 %	-10.98 %	1.48 %	-23.85 %	10.01 %
Receivable Turnover Ratio (TTM)	8.39	7.04	6.6	6.08	5.23
CLVR's Total Ranking	# 1702	# 1907	# 2723	# 2279	# 3125
Accounts Receivable average collection period days	43	52	55	60	70
Seq. Receivable Change	-48.05 %	-32.59 %	-2.19 %	17.58 %	-13.08 %
Seq. Revenue Change	66.89 %	-37.75 %	18.8 %	-13.78 %	39.61 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 70
Healthcare Sector	# 166
Overall Market	# 1702

Receivable Turnover Ratio Statistics
High	Average	Low
8.39	4.62	1.2
(Dec 31 2023)		(Mar 31 2022)

CLVR Company Profile • Back to CLVR Efficiency Comparisons • Compare CLVR Receivables Turnover Ratio to its Competitors

Financial Statements
Clever Leaves Holdings Inc 's Accounts Receivable	$ 1 Millions	Visit CLVR's Balance sheet
Clever Leaves Holdings Inc 's Sales TTM	$ 17 Millions	Visit CLVR's Income Statement
Sources of CLVR's Revenues		Visit CLVR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CLVR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CLVR's Growth Rates	CLVR's Roa	CLVR's Inventory Turnover Ratio	CLVR's Dividend Comparisons
CLVR's Profitability Ratios	CLVR's Roi	CLVR's Asset Turnover Ratio	CLVR's Dividend Growth
CLVR's Valuation Ratios	CLVR's Roe	CLVR's Financial Strength Ratios	CLVR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2023	Receivable at quarter ending Dec 31 2023
Vivos Therapeutics Inc	49.24	$ 13.271 Millions	$ 0.270 Millions
Spero Therapeutics Inc	48.91	$ 103.781 Millions	$ 2.122 Millions
Vbi Vaccines Inc	48.71	$ 8.682 Millions	$ 0.178 Millions
Sangamo Therapeutics Inc	46.81	$ 176.232 Millions	$ 3.765 Millions
Nektar Therapeutics	46.58	$ 90.122 Millions	$ 1.935 Millions
Cytomx Therapeutics Inc	45.78	$ 101.214 Millions	$ 2.211 Millions
Marpai Inc	45.55	$ 37.155 Millions	$ 0.816 Millions
Greenbrook Tms Inc	44.64	$ 166.476 Millions	$ 3.730 Millions
Stoke Therapeutics Inc	44.57	$ 8.780 Millions	$ 0.197 Millions
Nature s Sunshine Products inc	43.15	$ 445.127 Millions	$ 10.315 Millions
Janux Therapeutics Inc	43.11	$ 8.083 Millions	$ 0.188 Millions
Fusion Pharmaceuticals Inc	41.57	$ 2.068 Millions	$ 0.050 Millions
Hookipa Pharma inc	41.46	$ 20.129 Millions	$ 0.485 Millions
Onemednet Corporation	41.32	$ 1.570 Millions	$ 0.038 Millions
Nanobiotix S a	40.01	$ 40.552 Millions	$ 1.014 Millions
Ontrak Inc	39.70	$ 11.800 Millions	$ 0.297 Millions
23andme Holding Co	38.44	$ 246.722 Millions	$ 6.419 Millions
Lifemd Inc	37.05	$ 151.002 Millions	$ 4.075 Millions
Wearable Health Solutions, Inc.	36.72	$ 0.600 Millions	$ 0.016 Millions
Electrocore Inc	34.66	$ 15.226 Millions	$ 0.439 Millions
Sonida Senior Living Inc	34.44	$ 255.322 Millions	$ 7.413 Millions
Vireo Growth Inc.	34.09	$ 88.133 Millions	$ 2.586 Millions
Prothena Corporation Public Limited Company	33.71	$ 91.370 Millions	$ 2.710 Millions
Adaptimmune Therapeutics Plc	29.72	$ 60.281 Millions	$ 2.029 Millions
Invo Fertility Inc	27.97	$ 3.021 Millions	$ 0.108 Millions
Aesthetic Medical International Holdings Group Limited	26.71	$ 100.824 Millions	$ 3.775 Millions
National Vision Holdings Inc	26.38	$ 2,126.468 Millions	$ 80.611 Millions
Orchestra Biomed Holdings Inc	25.56	$ 2.760 Millions	$ 0.108 Millions
Cv Sciences Inc	25.51	$ 15.085 Millions	$ 0.591 Millions
Evotec Se	25.30	$ 875.197 Millions	$ 34.597 Millions

Date modified: 2026-06-22T16:30:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.